confid merit esrx deal
industri lead medic trend continu get better base
favor trend improv medic cost trend outlook
bp rang vs previous driven strength
major cost categori fact say categori
trend low-mid singl digit
seen growth market see good growth
busi compani pleas posit
offer put forward growth driven number factor
includ demograph continu uptick custom satisfact
rate vs fee servic expans adjac counti favor
rate momentum plan roll offer one total
new market
baselin ep updat outlook includ
mln favor net pyd estim mln unfavor
net impact relat hif moratorium contract renew
time issu thu baselin ep roughli
rais estim pt rais ep
estim respect
probabl weight price target put
probabl ci-esrx deal go price-to-earnings deal
approv scenario deal reject scenario risk rate
pt includ slower expect growth unexpect pick-up
util deal integr relat risk event esrx deal approv
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
headquart bloomfield ct global health servic
health global supplement benefit group disabl
life
price aug rate outperform target price analyst rice
profit tax
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
total debt capit
blue sky valuat asum ci-esrx deal approv
pro-forma compani report major disrupt among
client well manag settlement litig
scenario believ pro-forma compani trade
grey sky valuat assum ci-esrx deal reject
stand-alon compani see continu disrupt
medicar advantag busi scenario see ci
share trade ex-shar buy-back stand-alon ep
 close
highlight manag
post quarterli confer call discuss ci manag review
result medic cost/mlr trend commerci busi expect
text list question compani respons answer verbatim
put compani answer proper context give-and-tak format
question respect doj review david said call day
window start compani respond second request
month hear right suggest might hear someth
answer ye that right ci expect certifi complianc second request
sometim august enter time agreement doj doj
expect render decis within day certifi request squar
hear someth novemb
question confirm requir sharehold vote percentag
deal approv absente count deal
answer that correct
question final question call break-up fee
understand owe termin fee deal reject
sharehold right
answer would direct merger agreement answer
question morn reiter goal ep year
follow combin esrx target initi base
stand-alone plu esrx earn outlook
move sinc understand differ put
take consid see potenti upsid stand-alon ci ep target
answer strong rais guidanc pleas
result compani go re-project outlook time
increas confid convict abil deliv ep target
question call discuss around esrx chang languag
around pass pass-through number previous seem
figur apples-to-appl elabor differ
two number
answer two separ measur look specif
rebat that esrx talk pass directli client
comprehens measur rebat also price reduct
discount within core framework esrx go-forward custom client
comprehens get valu creat esrx
question rebat wouldnt number higher pass-through
say rebat get pass along look
way pbm get paid your say get pass along
answer comprehens rebat rebat price reduct
discount
question price reduct discount pass
answer denomin rebat purchas discount price reduct
denomin rebat
question view compar figur industri
answer believ esrx put figur in-lin
metric industri speak someth broader rebat
question cigna revenu almost howev full year
compani guid approxim y/i growth would impli
moder y/i growth roughli talk
driver
answer pleas increas revenu guidanc approxim
bp previou guidanc rel talk past
individu busi pattern enrol higher toward earli part
year
question individu busi pattern main swing would call
question much favor risk adjust true-up contribut
commerci quarter y/i impact
answer that wasnt impact alreadi adjust accrual
final number came pretti much line expect
question follow question medic cost trend outlook
improv bp rang vs previous
peer talk favor inpati pharmaci
trend outpati seem trend slightli higher primarili
continu shift procedures/car inpati outpati
experienc phenomenon comment
answer see strength across board major trend categori
categori trend low-mid singl digit pleas
compon trend overal trend outlook
question follow respect commerci individu busi
hix live off-exchang compliant live off-exchang non-
live note call expect profit improv
vs pretti much pre-tax margin busi
outlook revenu busi base
individu small group file review seem compani plan
signific exit expans market fair
answer pleas result individu thu far taken
measur approach toward individu last sever year solut tie
product offer highli effect physician collabor particular
market compani hasnt talk specif margin earn
individu busi profit busi look
doesnt specif exit entri discuss point reiter bia
particip make decis goe throughout year
question previous talk grow enrol
compani attribut market growth year market exit
lack expans new market chang
enrol expect ytd growth see
margin vs low-singl digit
answer updat growth guidanc doesnt expect
materi differ rel project term margin
histor talk busi low-mid singl digit after-tax rang
probabl toward low end rang
question bid talk approach
expect enrol margin trend improv vs
nice tailwind rate updat hif moratorium improv
rate bit vs
answer earli call custom growth next year
quit pleas posit offer put forward see growth
number front demograph marketplac continu uptick
custom satisfact rate expans adjac counti plan
plan move one total new market
track record number year ago pleas resum expans
addit plan member enabl provid
attract benefit offer custom overal
anticip good growth medicar advantag
question comment commerci nation account sell season
thought growth busi next year
answer made public comment point regard nation
account sell season particular
answer economi well direct help
question call modestli elev life insur claim
quarter compani flag solid disabl favor life result seem
trend busi improv sequenti discuss driver
compani net margin segment best trend
seen sinc anyth unusu quarter margin
answer group disabl life solid disabl favor life perform
quarter ci long term margin target busi mid-to-high singl digit tax
ci oper target rang noth unusu caus
margin bit higher quarter two risk busi
variabl result ci pleas result
question cigna global supplement benefit net earn mln
guidanc mln full year would impli moder
color
economi begin creat
in-contract growth
answer ci see season busi particularli korea back half
year usual govern remind citizen get health screen
typic tend drive uptick util piec regard
rate pace ci invest spend ci see littl bit uptick back half
rel first part year given strong result year
question tax rate segment use tax rate
segment rest year favor unfavor
currenc impact busi
answer ci guid tax rate segment term currenc impact
see quarter ci grew top-line would
quarter quarter currency-adjust basi adjust currenc
earn impact million favor quarter
capit structur deploy
question end parent compani cash billion
compani expect bln avail bln avail use
mln pay debt mln share buy-back compani
use mln acquir onepath life insur new zealand anz
expect close see opportun like onepath
avail intern market uniqu opportun
much revenu earn expect deal annual
basi assum includ global supplement benefit
answer ci pleas signific amount cash flow busi
gener outlin sourc use thu far one thing ci would
like comment excit onepath opportun ci alway
look opportun global space time time come one
somewhat uniqu realli hit sweet spot term product offer
consist ci tradit life accid health-typ product
distribut channel open addit distribut channel ci
market ci know exclus arrang anz lead
bank new zealand realli attract opportun ci contribut
standpoint ci disclos amount revenu earn ci said
think modestli accret includ global
question call david seem excit use telemedicin tool
technolog current contract telemedicin provid like
teladoc american doctor demand etc commerci risk
busi medicar advantag busi david also note call
work telemedicin partner develop
capabl compani refer
answer ye ci number contract place varieti telemedicin
provid rang servic offer fairli broad term care deliveri care
coach behavior servic fit conveni anoth modal
choice-bas framework ci talk ci work
collabor partner tri jointli develop capabl ci partner
varieti provid rather one
question respect season note outlook
includ pyd pyd second say
reflect season individu busi price effect
associ suspens hif quantifi impact
hif moratorium result
answer hif moratorium regard impact time aspect
commerci busi ci talk million after-tax
season noth ordinari
question respect split repres
remain fell current consensu impli similar split
ep ep growth individu busi
drag relat hif moratorium shouldnt portion slightli higher
compar
answer ci made public comment rel season howev look
last three year histor gener averag split
question realiz given guidanc consid
guidanc take pyd first half hif drag
anyth els unusu number keep
mind think growth y/i
answer thing ci call year pyd fourth quarter million hif
compani mention price
